6990 — Sichuan Kelun-Biotech Biopharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$37.42bn
- HK$34.79bn
- CNY1.54bn
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -890 | -567 | -468 |
Depreciation | |||
Amortisation | |||
Non-Cash Items | 102 | 195 | 177 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | 279 | 34.5 | 276 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Payable / Accrued Expenses | |||
Change in Other Liabilities | |||
Cash from Operating Activities | -486 | -271 | 59.6 |
Capital Expenditures | -94.7 | -39 | -82.3 |
Purchase of Fixed Assets | |||
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | 0.359 | 6.84 | -943 |
Sale of Fixed Assets | |||
Sale/Maturity of Investment | |||
Purchase of Investments | |||
Cash from Investing Activities | -94.4 | -32.1 | -1,025 |
Financing Cash Flow Items | -40 | -2.93 | -10 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 647 | 313 | 2,382 |
Foreign Exchange Effects | |||
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 65.6 | 11.2 | 1,436 |